摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,5-dimethoxybenzylidene-2,4-thiazolidinedione

中文名称
——
中文别名
——
英文名称
3-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,5-dimethoxybenzylidene-2,4-thiazolidinedione
英文别名
(5E)-5-[[3,4-dimethoxy-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione
3-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,5-dimethoxybenzylidene-2,4-thiazolidinedione化学式
CAS
——
化学式
C27H31NO4S
mdl
——
分子量
465.613
InChiKey
DFNQOHRABNIMCQ-LPYMAVHISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.3
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    89.9
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Substituted heterocycles for the treatment of diabetes and other diseases
    申请人:Pfahl Magnus
    公开号:US20060004059A1
    公开(公告)日:2006-01-05
    The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
    本发明涉及公式(I)的某些取代杂环,其在治疗与脂质和碳水化合物代谢有关的疾病中有用,例如2型糖尿病,脂肪细胞分化,不受控制的增殖(如淋巴瘤,霍奇金病,白血病,乳腺癌,前列腺癌或癌症总体)和炎症(如骨关节炎,类风湿性关节炎,克罗恩病或炎性肠病)。
  • Imidazolidinedione derivatives for the treatment of diabetes and other diseases
    申请人:Pfahl Magnus
    公开号:US20050070581A1
    公开(公告)日:2005-03-31
    The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
    本发明涉及某些式(I)的取代杂环,其在治疗与脂质和碳水化合物代谢有关的疾病方面是有用的,例如2型糖尿病、脂肪细胞分化、不受控制的增殖,如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或普遍的癌症;以及炎症,例如骨关节炎、类风湿性关节炎、克罗恩病或炎性肠病。
  • Thiazolidinedione derivatives for the treatment of diabetes and other diseases
    申请人:Maxia Pharmaceuticals, Inc.
    公开号:US20030153606A1
    公开(公告)日:2003-08-14
    The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease. 1
    本发明涉及公式(I)的某些取代杂环,其在治疗与脂质和碳水化合物代谢相关的疾病方面有用,例如2型糖尿病、脂肪细胞分化、不受控制的增殖,例如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般的癌症;以及炎症,例如骨关节炎、风湿性关节炎、克隆氏病或炎性肠病。
  • Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
    申请人:Incyte San Diego Incorporated
    公开号:EP1593677A2
    公开(公告)日:2005-11-09
    The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatiod arthritis, Crohn's Disease or Inflammatory Bowel Disease.
    本发明涉及某些取代的式(I)杂环,可用于治疗与脂质和碳水化合物代谢有关的疾病,如 2 型糖尿病、脂肪细胞分化、增殖失控,如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般癌症;以及炎症,如骨关节炎、风湿性关节炎、克罗恩病或炎症性肠病。
  • BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES
    申请人:Maxia Pharmaceuticals, Inc.
    公开号:EP1214304A1
    公开(公告)日:2002-06-19
查看更多